Tissue Providers for Stem Cell Research: The Dispossessed

$38.56 plus tax (Refund Policy)

Buy Article:


Stem cell (SC) science is part of the growing trend of emerging technologies which depend for their success on the physical contribution of human raw materials—that is, tissues such as ova and embryos—by willing providers. These vital contributors, without whom many SC research projects would simply fail to be undertaken, are however excluded by UK law from sharing in the potential commercial successes that will accompany therapeutic advances and from receiving any appropriate financial recognition for the value of their contribution to the science. Tissue providers (TPs) are the dispossessed of the research arena.

This article argues for the acknowledgement of property rights for providers of human tissues for SC research. It provides an account of the concept of property in human tissue before going on to explore the impact of recent legal developments on this issue. It tackles objections which might be raised against the recognition of property in human tissue, illustrating the ways in which each fails to overcome the argument that excised human tissues are property. It demonstrates how the law's bestowal of control over the use of such tissues is indicative of a property relationship between provider and their tissue. Finally, it suggests a system of recompense which might be implemented to provide payments which reflect the role which tissue providers play in the efforts to realise the therapeutic hopes of SC science.

Document Type: Research Article

DOI: http://dx.doi.org/10.5235/175799610794046195

Publication date: December 1, 2010

More about this publication?
  • Stem cell research, cloning, GMOs ... How do regulations effect such emerging technologies? What impact do new technologies have on law? And can we rely on technology itself as a regulatory tool?

    The meeting of law and technology is rapidly becoming an increasingly significant (and controversial) topic. Law, Innovation and Technology is, however, the only journal to engage fully with it, setting an innovative and distinctive agenda for lawyers, ethicists and policy makers. Spanning ICTs, biotechnologies, nanotechnologies, neurotechnologies, robotics and AI, it offers a unique forum for the highest level of reflection on this essential area.

  • Editorial Board
  • Submit a Paper
  • Subscribe to this Title
  • Email alerts (Hart books and journals)
  • Sample Paper
  • Publisher's Website
  • ingentaconnect is not responsible for the content or availability of external websites
Related content



Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more